A NK3 receptor antagonist compound (NK3RA) for use in a method for the treatment of polycystic ovary syndrome (PCOS)
- 专利权人:
- AstraZeneca AB
- 发明人:
- Gilmour, Peter Stewart,Ho, Tony,Kakkar, Rahul,Webber, Lorraine
- 申请号：
- AU2014255512
- 公开号：
- AU2014255512A1
- 申请日:
- 2014.04.14
- 申请国别(地区):
- AU
- 年份:
- 2015
- 代理人:
- 摘要：
- A method for treating polycystic ovarian syndrome and related conditions with a compound (I): or a pharmaceutically acceptable salt thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NK3 RECEPTOR ANTAGONIST COMPOUND (NK3RA) FOR USE IN A METHOD FOR THE TREATMENT OF POLYCYSTIC OVARY SYNDROME (PCOS)
- A NK3 RECEPTOR ANTAGONIST COMPOUND (NK3RA) FOR USE IN A METHOD FOR THE TREATMENT OF POLYCYSTIC OVARY SYNDROME (PCOS)
- nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (sop)
- PHARMACEUTICAL FORMULATIONS FOR TREATING ENDOMETRIOSIS, UTERINE FIBROIDS, POLYCYSTIC OVARY SYNDROME OR ADENOMYOSIS
- Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
